IMNM- Immunome, Inc.

Name: Immunome, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunome, Inc. (IMNM) has 13 insiders with recent SEC Form 4 filings, including 9 buys and 4 sells. IMNM is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Barchas Isaac	2.04M	$45.83M	-
CEO	Siegall Clay B	690.7K	$15.50M	-
Dir	Wagenheim Philip	341.1K	$7.66M	-
Other	Lechleider Robert	242.0K	$5.43M	-
CFO	Rosett Max	207.0K	$4.65M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 27, 2026	Siegall Clay B78	President And CEO	Buy	25,450	$19.67	$500,601.50	+3.8%	-	-
Mar 23, 2026	Wagenheim Philip	Director	Sell	65,000	$20.55	$1,335,626.00	-8.4%	-	-
Mar 11, 2026	Bienaime Jean Jacques68	Director	Buy	2,000	$21.84	$43,670.00	+2.7%	-	-
Dec 30, 2025	Siegall Clay B78	President And CEO	Buy	4,729	$21.15	$100,018.35	+0.7%	-8.9%	-
Dec 22, 2025	Barchas Isaac	Director	Sell	383,200	$21.74	$8,330,079.62	-8.6%	-5.8%	-
Dec 19, 2025	Siegall Clay B78	President And CEO	Buy	7,278	$20.48	$149,053.44	+0.9%	-2.8%	-
Dec 19, 2025	Tsai Philip76	Chief Technical Officer	Buy	10,000	$20.49	$204,900.00	+30.0%	-2.8%	-
Dec 18, 2025	Siegall Clay B78	President And CEO	Buy	46,511	$21.50	$999,986.50	+5.8%	+3.4%	-
Jun 3, 2025	Bienaime Jean Jacques68	Director	Buy	5,000	$9.38	$46,900.00	+15.9%	+0.2%	-
Mar 26, 2025	Siegall Clay B78	President And CEO	Buy	137,100	$7.29	$999,459.00	+20.5%	+25.8%	+187.9%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC